Lupin’s Escitalopram tablets are the AB-rated generic equivalent of Forest Laboratories’s Lexapro tablets, indicated for the treatment of major depressive disorder. The product will be introduced in the
Mr Kranda succeeds John McLaughlin, who resigned as CEO and member of the Anesiva board to pursue other business interests, while remaining a consultant to the company. Most
The Gravitas trial is designed to evaluate the use of the VerifyNow P2Y12 test to identify patients that exhibit a low response to antiplatelet therapy who are at
Irbesartan and hydrochlorothiazide tablets, indicated for the treatment of hypertension, are the generic version of Sanofi Aventis’s Avalide tablets. Currently, Mylan has 92 abbreviated new drug applications pending
In preclinical studies BaroFeron demonstrated enhanced pharmacological properties, both pharmacokinetics and pharmacodynamics, when compared to commercial interferon beta products. According to the company, BaroFeron has the potential to
The collaboration provides GlaxoSmithKline (GSK) access to Mpex’s novel efflux pump inhibitors (EPI) and related proprietary technology for use in combination with a variety of antibiotics. The collaboration
This request is in response to the negative opinion of May 30, 2008, in which the Committee for Medicinal Products for Human Use (CHMP) recommended the refusal of
Humira received approval for manufacturing and distribution in Japan on April 16, 2008, and was listed in the National Health Insurance drug price list on June 13, 2008.
The study was conducted in centres across the US and Europe. The full analysis set includes a total of 557 patients. The study was a randomized, double-blind, placebo-controlled,
The Phase I study showed that TZP-102 has excellent oral bioavailability in man and is safe and well-tolerated at all five doses (10-80 mg) tested. Most importantly, all
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.